Are Peptides Safe or Dangerous for Lyme Treatment?

15 Mar 2026 · 3 min
3:01

In this presentation, Dr. Diane Mueller explains the therapeutic potential of the peptide VIP (vasoactive inhibitory peptide). She outlines its well‑known role in promoting healthy gut motility and introduces its lesser‑known application for reducing neurological inflammation associated with conditions such as Lyme disease, mold exposure, toxic‑metal toxicity, and autoimmune disorders. Dr. Mueller emphasizes that while addressing root causes remains essential, VIP can serve as an adjunct to resolve lingering inflammation and restore cellular function. A major focus of the talk is the critical importance of using pharmaceutical‑grade, contaminant‑free peptides; she warns that many direct‑to‑consumer products may contain lipopolysaccharide (LPS), toxic metals, or other impurities. She provides practical guidance for patients seeking qualified peptide‑therapy clinicians and for healthcare providers looking for vetted peptide suppliers, offering to facilitate introductions. The overall message balances clinical insight with safety advocacy, encouraging informed, high‑quality peptide use as part of a comprehensive treatment plan.

Chapters

More from Dr.

8:30
youtube.com

Spot the Lyme Bullseye Rash Before It's Too Late

1d ago
8:30
youtube.com

How to fix a mold problem

1mo ago
8:38
youtube.com

Real Doctor: If You Had Chronic Disease, Peptides Would Be First

2mo ago
8:05
youtube.com

MCAS, Histamine And Why You Are So Sensitive To Treatment

3mo ago
youtube.com

Labs Normal But Still Sick? 7 Numbers Doctors Miss

4mo ago
youtube.com

What are typical symptoms especially neurological ones for Lyme disease HIGHRES

5mo ago
youtube.com

Is LYME DISEASE Linked To CD57?

5mo ago
youtube.com

Why Histamine Reactions Won't Stop (And What Helps)

5mo ago
youtube.com

What Your Doctor Is Not Telling You About Peptide and Pain

6mo ago
youtube.com

End Brain Fog Now with VIP!

6mo ago
youtube.com

Tested Negative for Lyme But Still Sick?

7mo ago
See all content